Confident Investing Starts With TipRanks Premium

Get 55% Off
TipRanks
Go Ultimate55% OFF

Cordlife Group (CLIFF) AI Stock Analysis

CLIFF

Cordlife Group

(Other OTC:CLIFF)

Rating:―N/A
Action:N/A
Date:―

No summary available

Positive Factors
Low LeverageVery low leverage and a sizable equity base reduce solvency pressure and provide financial flexibility while the company works to restore profitability. This conservative funding structure can help Cordlife sustain operations and pursue improvement without relying heavily on additional borrowing.
Negative Factors
Persistent LossesPersistent operating and net losses show that the current business model is not yet converting revenue into sustainable earnings. The deeply negative net margin can erode equity over time and limits internal funding for service development, operational investment, or expansion.

Cordlife Group (CLIFF) vs. SPDR S&P 500 ETF (SPY)

-40%-20%0%20%40%60%80%CLIFF+42.22%SPY+11.79%Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26
Market Cap
$32.88M
Dividend Yield
―
Average Volume (3M)
292
Price to Earnings (P/E)
-2.2
Beta (1Y)
-0.16
Revenue Growth
―
EPS Growth
―
Country
US
Employees
596
Sector
Healthcare
Sector Strength
51
Industry
Medical - Diagnostics & Research

Cordlife Group Business Overview & Revenue Model

Company Description

Established in Singapore in 2001, Cordlife Group Limited functions as an investment holding company, delivering cord blood banking solutions across a global footprint that includes Singapore, Hong Kong, India, Malaysia, and the Philippines. Its opera...

Cordlife Group Peers Comparison

Overall Rating

UnderperformOutperform
Sector (51)

Financial Indicators

CLIFF against its peers
NameOverall RatingMarket CapP/E RatioROEDividend YieldRevenue GrowthEPS Growth
SG:BSLSG:BSL66NeutralSGD 1.55B22.406.42%3.66%-3.18%6.71%
Sector *51Neutral$7.86B-0.30-43.30%2.27%22.53%-2.21%
SG:A50SG:A5048NeutralSGD 1.27B-41.13-6.42%―6.44%38.89%

* Healthcare Sector Average

Performance Comparison

-20%0%20%40%60%CLIFFSG:BSLSG:A50SG:40TSG:5WASG:TBDDDec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26
CLIFF and its peers over the selected period
Show on chartTickerCompany NamePriceChange% Change
CLIFFCordlife Group 0.130.0442.22%
SG:BSLRaffles Medical Group 0.82-0.14-14.58%
SG:A50Thomson Medical Group Ltd.0.05-0.01-20.00%
SG:40TISEC Healthcare Ltd0.31-0.02-6.91%
SG:5WAOUE Lippo Healthcare Limited0.050.0268.97%
SG:TBDDBangkok Dusit Medical Services Public Co Ltd Shs UnSp Singapore Depositary Receipt Repr 2/1 Sh1.500.042.74%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.